BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 22288464)

  • 41. Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.
    Ortqvist E; Brooks-Worrell B; Lynch K; Radtke J; Bekris LM; Kockum I; Agardh CD; Cilio CM; Lethagen AL; Persson B; Lernmark A; Reichow J; Oak S; Palmer JP; Hampe CS
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E310-8. PubMed ID: 20685858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vaccine for prevention of type 1 diabetes mellitus].
    Surković I; Suljević I; Ascić-Buturović B; Heljić B
    Med Arh; 2006; 60(3):198-9. PubMed ID: 16719238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-idiotypic immunity in autoimmunity.
    Bigazzi PE
    Ann N Y Acad Sci; 1986; 475():66-80. PubMed ID: 3538975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
    Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
    Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
    Dietrich G; Kaveri SV; Kazatchkine MD
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-cell autoimmunity.
    Fuchs YF; Adler K; Bonifacio E
    Methods Mol Biol; 2012; 933():265-74. PubMed ID: 22893413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.
    Harrison LC
    Mol Metab; 2021 Oct; 52():101288. PubMed ID: 34242821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Heat Shock Proteins in Type 1 Diabetes.
    Moin ASM; Nandakumar M; Diane A; Dehbi M; Butler AE
    Front Immunol; 2020; 11():612584. PubMed ID: 33584694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin and type 1 diabetes: immune connections.
    Culina S; Brezar V; Mallone R
    Eur J Endocrinol; 2013 Feb; 168(2):R19-31. PubMed ID: 23065992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmunity to tetraspanin-7 in type 1 diabetes.
    McLaughlin KA; Tombs MA; Christie MR
    Med Microbiol Immunol; 2020 Aug; 209(4):437-445. PubMed ID: 32314012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.
    Acevedo-Calado M; James EA; Morran MP; Pietropaolo SL; Ouyang Q; Arribas-Layton D; Songini M; Liguori M; Casu A; Auchus RJ; Huang S; Yu L; Michels A; Gianani R; Pietropaolo M
    Diabetes Care; 2017 Apr; 40(4):561-568. PubMed ID: 28174261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cytokine production of peripheral blood mononuclear cells reflects the autoantibody profile of patients suffering from type 1 diabetes.
    Labikova J; Vcelakova J; Ulmannova T; Petruzelkova L; Kolouskova S; Stechova K
    Cytokine; 2014 Oct; 69(2):189-95. PubMed ID: 24993165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of four diabetes specific autoantibodies in a single radioimmunoassay: an innovative high-throughput approach for autoimmune diabetes screening.
    Tiberti C; Yu L; Lucantoni F; Panimolle F; Spagnuolo I; Lenzi A; Eisenbarth GS; Dotta F
    Clin Exp Immunol; 2011 Dec; 166(3):317-24. PubMed ID: 22059988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perspectives in immunoregulation and autoimmunity.
    Cruse JM; Lewis RE
    Concepts Immunopathol; 1986; 3():1-16. PubMed ID: 3496159
    [No Abstract]   [Full Text] [Related]  

  • 56. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epibodies in autoimmunity: antisera against autoantibodies to the renal glomerular basement membrane react with idiotypes as well as with autoantigens.
    Bigazzi PE; Michaelson JH; Potter NT
    Autoimmunity; 1989; 5(1-2):3-16. PubMed ID: 2519016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases.
    Krause I; Hacham S; Gilburd B; Damianovitch M; Blank M; Shoenfeld Y
    Clin Immunol Immunopathol; 1995 Dec; 77(3):229-35. PubMed ID: 7586732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID).
    Petersen JS; Marshall MO; Baekkeskov S; Hejnaes KR; Høier-Madsen M; Dyrberg T
    Diabetologia; 1993 Jun; 36(6):510-5. PubMed ID: 8335172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of autoallergy to the pathogenesis in the NOD mice.
    Thyagarajan R; Banday V; Ding Z; Lejon K
    Autoimmunity; 2015; 48(5):298-304. PubMed ID: 25707684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.